Many children seeking asylum in the European Union originate from countries where tuberculosis (TB) infection is prevalent. A new research letter in the European Respiratory Journal investigates whether routinely screening those children for TB is an effective way to protect public health and to make sure that children who are affected are treated and well cared for.

Amsterdam, The Netherlands, 28 September, 2015: Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide, yet the majority of these patients are excluded from the early stages in the development of new, anti-tuberculosis drugs, according to findings presented today (29 September, 2015) at the European Respiratory Society’s International Congress 2015.

Lung conditions responsible for 1 in 10 of all deaths in Europe and cost EU countries at least 400 billion Euros annually; deaths due to lung cancer and COPD projected to increase over coming decades